๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Solid Cancers

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview IMA402 T Cell-Engaging Receptor Molecule (TCERยฎ) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites๐Ÿ“ Heidelberg๐Ÿ“ Heidelberg๐Ÿ“ Mannheim Immatics Biotechnologies GmbH ยท Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors NCT07408258Phase 13 sites๐Ÿ“ New York๐Ÿ“ Philadelphia๐Ÿ“ Houston OncoC4, Inc. ยท Tests: ONC-783 A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation NCT06908434Phase 11 site๐Ÿ“ Shanghai Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci128 tablets A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors NCT05866692Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Jinan TYK Medicines, Inc ยท Tests: TY-2699a VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment NCT07306338n/a1 site๐Ÿ“ Los Angeles University of Southern California ยท Tests: Non-Interventional Study Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site๐Ÿ“ Hangzhou Weijia Fang, MD ยท Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET NCT05093335EARLY Phase 11 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: [68Ga]-Pentixafor A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site๐Ÿ“ Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. ยท Tests: Autologous tumor infiltrating lymphocytes (TILs) Study of GS-2426 in Participants With Advanced Solid Tumors NCT07601243Phase 16 sites๐Ÿ“ Boston๐Ÿ“ Grand Rapids๐Ÿ“ East Brunswick Gilead Sciences ยท Tests: GS-2426 A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors NCT06311578Phase 110 sites๐Ÿ“ New York๐Ÿ“ Philadelphia๐Ÿ“ Pittsburgh Johnson & Johnson Enterprise Innovation Inc. ยท Tests: JNJ-87704916, Cetrelimab, Standard of Care PD(L)-1 NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors NCT05881525Phase 11 site๐Ÿ“ Chongqing TCRCure Biopharma Ltd. ยท Tests: TC-N201 cells, IL-2, Fludarabine, Cyclophosphamide, Nab-paclitaxel A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites๐Ÿ“ Beijing๐Ÿ“ Qinhuangdao๐Ÿ“ Zhengzhou Peking University Third Hospital ยท Tests: Autologous NK cells Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors NCT07487168Phase 11 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors NCT05142423Phase 1, Phase 21 site๐Ÿ“ Hangzhou Akeso ยท Tests: AK109+AK104 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment NCT06497010EARLY Phase 11 site๐Ÿ“ Guiyang The Affiliated Hospital Of Guizhou Medical University ยท Tests: Biological: PD-1, Biological: InnoPCV A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib Plasmodium Immunotherapy for Advanced Malignant Solid Tumors NCT04165590Phase 1, Phase 21 site๐Ÿ“ Kunming CAS Lamvac Biotech Co., Ltd. ยท Tests: Plasmodium immunotherapy 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT DXP-106 in Solid Tumor Patients. NCT07532018Phase 14 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai๐Ÿ“ Taiyuan Singlomics Biopharmaceuticals Zhuhai Co., Ltd. ยท Tests: DXP-106 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites๐Ÿ“ Atlanta๐Ÿ“ Nashville๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: GVV858, Fulvestrant, Letrozole A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors NCT05584670Phase 1, Phase 222 sites๐Ÿ“ Newark๐Ÿ“ Iowa City๐Ÿ“ Westwood Sanofi ยท Tests: SAR445877, Cetuximab, ADG126, Bevacizumab, Nivolumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy